Abexinostat

Abexinostat · Xynomic Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Abexinostat, covering 2025-04-10 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma [Phase 1]